Lorenzo Botto is a Rare/Genetic physician affiliated with Centers for Disease Control and Prevention. OpenAlex indexes 314 publications with 17,636 citations (h-index 62).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Mario Capecchi Dr
Salt Lake City, UT 841131103
Telephone
801-213-3599Provider last certified this registry record 28 Oct 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BioMarin Pharmaceutical Inc.Program year20251 payment
- Ipsen Biopharmaceuticals, IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2008–2023 per NIH RePORTER. The latest:
- Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN) Continuation
University of Utah
FY2023$615,667U01NS134351 - Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN) Phase 2 Supplement
University of Utah
FY2022$170,779U01HG010217 - Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN), Phase 2
University of Utah
FY2021$550,000U01HG010217
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997–2011
American Journal of Obstetrics and Gynecology
2019 - Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification
The American Journal of Human Genetics
2019 - De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias
The American Journal of Human Genetics
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Alicia Fry
Centers for Disease Control and Prevention
Matthew D. Ritchey
Centers for Disease Control and Prevention
Marc Fischer
Centers for Disease Control and Prevention
Cynthia Moore, MD
Centers for Disease Control and Prevention
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”